Jacobi Capital Management LLC Insulet Corp Transaction History

Jacobi Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$260.36 - $307.27 $15,621 - $18,436	-60 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$225.52 - $304.06 $3,608 - $4,864	16 Added 36.36%	60 $16,000
Q1 2021 May 11, 2021	BUY	$235.95 - $293.05 $4,954 - $6,154	21 Added 91.3%	44 $11,000
Q4 2020 Feb 08, 2021	SELL	$215.97 - $265.89 $1,079 - $1,329	-5 Reduced 17.86%	23 $6,000
Q3 2020 Oct 30, 2020	BUY	$192.55 - $236.59 $1,732 - $2,129	9 Added 47.37%	28 $7,000
Q2 2020 Aug 04, 2020	SELL	$159.17 - $224.73 $60,643 - $85,622	-381 Reduced 95.25%	19 $4,000
Q2 2020 Jul 27, 2020	BUY	$159.17 - $224.73 $62,076 - $87,644	390 Added 3900.0%	400 $4,000
Q1 2020 Apr 24, 2020	BUY	$130.01 - $216.44 $1,300 - $2,164	10 New	10 $2,000

696

62.6M

640K

841K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.